Wockhardt lost 1.67% to Rs 757.50 at 11:08 IST on BSE after consolidated net profit fell 98% to Rs 3 crore on 14% decline in sales to Rs 1029 crore in Q2 September 2014 over Q2 September 2013.
The Q2 result was announced after market hours on Monday, 3 November 2014.
Meanwhile, the S&P BSE Sensex was up 89.46 points or 0.32% at 27,949.84.
On BSE, so far 2.49 lakh shares were traded in the counter as against average daily volume of 4.38 lakh shares in the past one quarter.
The stock hit a high of Rs 766.95 and a low of Rs 736 so far during the day. The stock had hit a 52-week low of Rs 336.60 on 16 December 2013. The stock had hit a 52-week high of Rs 886.50 on 15 September 2014.
The stock had underperformed the market over the past one month till 3 November 2014, sliding 4.36% compared with Sensex's 4.86% rise. The scrip had, however, outperformed the market in past one quarter, jumping 15.51% as against Sensex's 9.34% rise.
The mid-cap company has equity capital of Rs 55.02 crore. Face value per share is Rs 5.
Wockhardt's operating profit declined 16% to Rs 165 crore in Q2 September 2014 over Q2 September 2013. Operating profit margin declined to 16% in Q2 September 2014, from 16.4% in Q2 September 2013.
Wockhardt said it increased its research spend significantly and the same is now at 10.7% to sales at Rs 110 crore and including capital expenditure is at 11.1% to sales in Q2 September 2014.
The company incurred capital expenditure of Rs 194 crore in the first half of FY 2015.
Wockhardt's board of directors at its meeting held on 3 November 2014, approved payment of interim dividend of Rs 20 per share for the year ending 31 March 2015.
Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, highly quality medicines for a healthier world. It is India's leading research-based global healthcare enterprise with relevance in the fields of pharmaceuticals, biotechnology and a chain of advanced super speciality hospitals.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app